Where does Lytix Biopharma AS rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lytix Biopharma AS ranks #26,783 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lytix Biopharma AS hold?

Lytix Biopharma AS holds 10 US utility patents granted between 2015 and 2025, spanning 5 technology areas.

What is Lytix Biopharma AS's Innovation Score?

Lytix Biopharma AS has an Innovation Score of 24.1 out of 100 (14th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Lytix Biopharma AS's patent grant rate increasing or decreasing?

Lytix Biopharma AS's recent grant velocity is -71% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Lytix Biopharma AS's patents?

Lytix Biopharma AS's patents average 13.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lytix Biopharma AS patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Lytix Biopharma AS

Q: What technology areas does Lytix Biopharma AS focus on?

Lytix Biopharma AS's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 9 patents. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lytix ranks #26,783 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 5 technology areas.

#26,783
of 49,997 US assignees by volume: 14th percentile
by Innovation Score (24.1/100): 13.1
avg claims per patent: -71%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26783 · Foreign Corporation #26,783 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,783/49,997
PHOTO-FINISH Laborie Medical
CPC-NARROW A61K · 5 areas
INNOV-THIN 24.1/100
CLAIMS-RICH 13.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -71% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Laborie Medical Technologies Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Lytix Biopharma AS · this assignee

24
3D Lighting… · lowest

7

What this shows Lytix's Innovation Score is 24.1/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Lytix's grants concentrate

Lytix Biopharma AS is a focused PatentsView assignee: 5 CPC subclasses with 90% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2016. By volume, Lytix sits between Lumiphore, Inc. and Laminar, Inc..

Lumiphore

10
Lumlux

10
Luxium Solutions

10
Lynk Pharmaceutic…

10
Laborie Medical

10
Lafayette College

10
Lakeside Software

10
Laminar

10
Lytix Biopharma AS ◀

10

What this shows Lytix holds 10 patents at rank #26,744, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lytix

By rank, the assignees closest to #26,744 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Lytix's primary technology class.

Lytix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 14th percentile higher than 14% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Lytix Biopharma AS patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	40.0%
2016	1	10.0%
2017	1	10.0%
2019	1	10.0%
2021	2	20.0%
2025partial year	1	10.0%

Which technologies does Lytix Biopharma AS patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

C07K - Peptides 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

Y02A - Technologies FOR Adaptation TO Climate Change 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#26,783

of 49,997 tracked assignees

Innovation Score

24.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Lytix Biopharma AS's patent record in context - here's where to go next.

Lytix Biopharma AS's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 90% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #26,783 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lytix Biopharma AS against Lumiphore, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.